The company Centre Spécialités Pharmaceutiques (CSP) is responsible for Exploitant activities on behalf of Piramal Critical Care Limited and CSP monitors pharmacovigilance and medical information: any adverse reactions related to PCC pharmaceutical specialities and medical questions relating to these products must be reported to CSP’s Pharmacovigilance Department.